Anti-KIR monoclonal antibody

anti-KIR monoclonal antibody · Innate Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-KIR monoclonal antibody, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) [Phase 2]

See pricing